AI assistant
UNITED THERAPEUTICS Corp — Director's Dealing 2021
Oct 7, 2021
30320_dirs_2021-10-07_32c3f35d-d53c-43c1-a2ae-d1540e0b1880.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: UNITED THERAPEUTICS Corp (UTHR)
CIK: 0001082554
Period of Report: 2021-10-07
Reporting Person: MAHON PAUL A (EVP & General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-10-07 | Common Stock | M | 6000 | $111.00 | Acquired | 42369 | Direct |
| 2021-10-07 | Common Stock | S | 2993 | $190.065 | Disposed | 39376 | Direct |
| 2021-10-07 | Common Stock | S | 2136 | $190.5847 | Disposed | 37240 | Direct |
| 2021-10-07 | Common Stock | S | 871 | $191.9529 | Disposed | 36369 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-10-07 | Stock Options | $111.00 | M | 6000 | Disposed | 2028-03-15 | Common Stock (6000) | Direct |
Footnotes
F1: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
F2: This transaction was executed in multiple trades at prices ranging from $189.33 to 190.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: This transaction was executed in multiple trades at prices ranging from $190.42 to $191.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4: This transaction was executed in multiple trades at prices ranging from $191.80 to $192.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.